J B Chemicals merges into Torrent Pharma, effective July 8, 2026
AI Market Summary
J B Chemicals' amalgamation into Torrent Pharmaceuticals is effective July 8, 2026, following NCLT approval and ROC filing. JB Chemicals is dissolved without winding up, its listing will cease, and shareholders receive Torrent shares at a 51-for-100 exchange ratio (appointed date Jan 21, 2026). Market impact is mainly idiosyncratic to the companies involved, with limited broader cross-asset implications.
Impact level
● Low
Affected assets
NCCOGOLD2USD/USDT-1.09%
AI Insight · NCCOGOLD2USD/USDTAI Insight
● Neutral
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
The merger-by-absorption of J B Chemicals with Torrent Pharmaceuticals took effect on July 8, 2026, resulting in J B Chemicals being dissolved from that date without continuing as a separate entity. The amalgamation is set with an appointed date of January 21, 2026, and provides a share exchange ratio of 51 Torrent Pharma shares (face value ₹5) for every 100 J B Chemicals shares (face value ₹1). The scheme was approved by the NCLT Ahmedabad Bench and has been registered with the Registrar of Companies, Ahmedabad. J B Chemicals shares will be delisted, and shareholders’ rights will be converted into Torrent Pharma shares.
